Alkermes PLC (ALKS)
24.05
-0.21
(-0.87%)
USD |
NASDAQ |
May 10, 16:00
24.06
+0.02
(+0.06%)
After-Hours: 20:00
Alkermes 1 Year Total Returns (Daily): -23.33% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 10, 2024 | -23.33% |
May 09, 2024 | -21.54% |
May 08, 2024 | -22.03% |
May 07, 2024 | -16.50% |
May 06, 2024 | -18.17% |
May 03, 2024 | -16.06% |
May 02, 2024 | -16.31% |
May 01, 2024 | -16.17% |
April 30, 2024 | -14.05% |
April 29, 2024 | -12.85% |
April 26, 2024 | -13.04% |
April 25, 2024 | -19.90% |
April 24, 2024 | -15.52% |
April 23, 2024 | -17.43% |
April 22, 2024 | -18.07% |
April 19, 2024 | -18.60% |
April 18, 2024 | -18.77% |
April 17, 2024 | -18.44% |
April 16, 2024 | -19.01% |
April 15, 2024 | -18.16% |
April 12, 2024 | -15.71% |
April 11, 2024 | -13.35% |
April 10, 2024 | -9.61% |
April 09, 2024 | -8.52% |
April 08, 2024 | -11.26% |
Date | Value |
---|---|
April 05, 2024 | -11.07% |
April 04, 2024 | -11.31% |
April 03, 2024 | -8.16% |
April 02, 2024 | -5.04% |
April 01, 2024 | -3.37% |
March 28, 2024 | -0.81% |
March 27, 2024 | 0.89% |
March 26, 2024 | 1.09% |
March 25, 2024 | 3.10% |
March 22, 2024 | 5.65% |
March 21, 2024 | 1.70% |
March 20, 2024 | 4.06% |
March 19, 2024 | 6.42% |
March 18, 2024 | 5.76% |
March 15, 2024 | 8.00% |
March 14, 2024 | 7.68% |
March 13, 2024 | 8.15% |
March 12, 2024 | 6.99% |
March 11, 2024 | 7.48% |
March 08, 2024 | 8.90% |
March 07, 2024 | 8.91% |
March 06, 2024 | 6.32% |
March 05, 2024 | 9.21% |
March 04, 2024 | 9.80% |
March 01, 2024 | 10.45% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.27%
Minimum
Mar 18 2020
98.05%
Maximum
Oct 26 2021
0.09%
Average
3.16%
Median
Nov 20 2023
1 Year Total Returns (Daily) Benchmarks
Endo International PLC (DELISTED) | -99.04% |
Jazz Pharmaceuticals PLC | -19.70% |
Medtronic PLC | -4.24% |
Perrigo Co PLC | -12.82% |
Iterum Therapeutics PLC | 34.78% |